Evidence map›Paper›PMID 41920264›Full record

ReviewCurrent allergy and asthma reports2026

A Parade of Persistent and Emerging Contact Allergens - A Clinical Update.

Malin Glindvad Ahlström, Wolfgang Uter, Jakob Ferløv Baselius Schwensen, Christoffer Kursawe Larsen, Rebekka Søgaard, Jeanne Duus Johansen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Malin Glindvad AhlströmNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte Hospitalsvej 20A, Hellerup, 2900, Denmark. malin.glindvad.ahlstroem.01@regionh.dk.ORCID 0000-0003-2092-7826
Wolfgang UterDepartment of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-4498-3710
Jakob Ferløv Baselius SchwensenNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte Hospitalsvej 20A, Hellerup, 2900, Denmark.ORCID 0009-0007-9756-656X
Christoffer Kursawe LarsenNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte Hospitalsvej 20A, Hellerup, 2900, Denmark.ORCID 0000-0003-2989-9198
Rebekka SøgaardNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte Hospitalsvej 20A, Hellerup, 2900, Denmark.ORCID 0009-0004-7749-0383
Jeanne Duus JohansenNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte Hospitalsvej 20A, Hellerup, 2900, Denmark.ORCID 0000-0002-3537-8463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewClinical management of allergic contact dermatitis (ACD) is increasingly challenging due to the growing number of allergens, complex exposure patterns, and evolving regulatory frameworks. This review aims to provide clinicians with an updated overview of well-known as well as new and emerging allergens relevant to the diagnosis and management of ACD. RECENT

findingsRecent literature highlights changing exposure patterns and the identification of several new and emerging allergens, particularly in rapidly expanding consumer markets such as cosmetics and products associated with medical devices. In addition, updated evidence has refined the clinical relevance of established allergen groups, including fragrances, metals, rubber chemicals, acrylates, and preservatives. Post-marketing surveillance of products and clinical patch test data continue to play an important role in detecting novel sensitizers and shifting exposure scenarios. Clinicians must remain vigilant, as exposure patterns continue to evolve with the introduction of new ingredients and products while established allergens persist. Ongoing surveillance and updated clinical awareness are essential to ensure accurate diagnosis and prevention of ACD.

Indexed as

AllergensDermatitis, Allergic ContactCosmeticsHumansPatch TestsAllergensCosmeticsAcrylatesAllergic contact dermatitisContact allergyCosmetovigilanceFragrancesMetalsPreservativesRubber

Identifiers

PMID41920264

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.